DiaSys Corporation Announces Satisfaction Of Requirements For Continued Listing

Published: Nov 27, 2006

WATERBURY, Conn., Nov. 20 /PRNewswire-FirstCall/ -- DiaSys Corporation On November 15, 2006, DiaSys Corporation (the "Company") filed its Annual Report on Form 10-KSB for its fiscal year ended June 30, 2006. Accordingly, the Company has satisfied requirements for continued listing of its Common Stock on the OTC Bulletin Board under the symbol DYXC.OB.

DiaSys Corporation designs, develops, manufactures and distributes proprietary medical laboratory equipment, consumables and infectious disease test-kits to healthcare & veterinary laboratories worldwide. Headquartered in Waterbury, Connecticut USA, the Company operates in Europe through its wholly owned subsidiary based in Wokingham, England and through distributors in South America. DiaSys, Parasep and Urisep are registered trademarks of DiaSys Corporation.

This press release contains forward-looking statements within the meaning of, and made pursuant to, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on Form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company.

DiaSys Corporation

CONTACT: Gregory Witchel, Chief Executive Officer of DiaSys Corporation,+1-203-755-5083

Back to news